期刊文献+

盐酸苄丝肼化学稳定性影响因素的研究 被引量:3

Study on the influencing factors of chemical stability of Benserazide Hydrochloride
下载PDF
导出
摘要 目的考察影响盐酸苄丝肼稳定性的因素。方法建立用于测定盐酸苄丝肼含量的高效液相色谱法。在此基础上,考察溶剂p H、光线、氧气、温度、湿度对盐酸苄丝肼稳定性的影响。结果所建立的含量测定方法符合方法学要求。考察结果表明,溶剂的p H越大,盐酸苄丝肼越不稳定;光线对盐酸苄丝肼稳定性有影响,需遮光保存;在氧气的作用下,盐酸苄丝肼会发生氧化现象,加入相对于药物的质量分数25%的维生素C后,12 h内稳定性良好;温度与湿度的变化对盐酸苄丝肼化学稳定性有影响。结论通过控制外部条件,有望改善盐酸苄丝肼的化学稳定性。 Objective To investigate the influencing factors of chemical stability of Benserazide Hydrochloride. Meth-ods The HPLC method for determining the content of Benserazide Hydrochloride was established. And the influencing factors including solvent pH, light, oxygen, temperature and humidity were investigated. Results The HPLC method for the determination of Benserazide Hydrochloride was in conformity with methodological requirements. In the solution which had higher pH, the Benserazide Hydrochloride was less stable. Light influenced chemical stability of Benserazide Hydrochloride, so it should be kept away from light. Benserazide Hydrochloride was oxidized. But when added 25%Vitamin C (the mass ratio of antioxidants to drug, W/W ) to the Benserazide Hydrochloride solution, the drug was stable within 12 h. The temperature and humidity affected the chemical stability of Benserazide Hydrochloride, too. Conclu-sion If the external conditions are controlled, the chemical stability of Benserazide Hydrochloride will be improved.
出处 《中国医药导报》 CAS 2014年第35期4-7,11,共5页 China Medical Herald
基金 新疆维吾尔自治区科技计划项目(编号201110106) 新疆维吾尔自治区乌鲁木齐市科学技术计划项目(编号G121320003) 新疆研究生科研创新项目(编号XJGRI2013084)
关键词 盐酸苄丝肼 高效液相色谱法 化学稳定性 影响因素 Benserazide Hydrochloride High performance liquid chromatography Chemical stability Influencing factors
  • 相关文献

参考文献16

  • 1Paul HG,Jason MM,Robert CH, et al. Parkinson's disease among American Indians and Alaska natives: a nation- wide prevalence study [J]. Mov Disord, 2012,27 ( 11 ) : 1456- 1459. 被引量:1
  • 2Navailles S,Lagiere M ,Contini A,et al. Multisite intrae- erebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinso- nian brain [J]. ACS Chem Neurosci ,2013,4(5) :680-692. 被引量:1
  • 3Lipski J, Nistico R, Berretta N, et al. L-DOPA : a scape- goat for accelerated neurodegeneration in Parkinson's dis- ease [J]. Prog Neurobiol, 2011,94 (4) : 389-407. 被引量:1
  • 4Di Stefano A, Sozio P, Cerasa LS, et al. L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment [J]. Curr Pharm Des,2011,17(32):3482-3493. 被引量:1
  • 5徐娉,张璟.左旋多巴治疗帕金森病用药方法及疗效观察[J].中国实用内科杂志,2003,23(7):443-444. 被引量:3
  • 6蔡云鹏,马柳青,张文君,王兆敏,张袁魁,朱云婷,袁伟恩.苄丝肼微球的体外释放行为[J].现代生物医学进展,2012,12(11):2158-2159. 被引量:1
  • 7Goole F,Vanderbist K,Amighi. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms [J]. International Journal of Pharmaceutics, 2007, (334) :35-41. 被引量:1
  • 8Goole PH,Deleuze F,Vanderbist,et al. New levodopa sus- tained-release floating minitablets coated with insoluble acrylic polymer [J]. European Journal of Pharmaceutics and Biopharmaceutics ,2008, (68) :310-318. 被引量:1
  • 9Ren TY,Yang XX,Wu N ,et al. Sustained-release formu- lation of levodopa methyl esterPoenserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats [J]. Neuroscience Letters, 2011, (502 ) : 117 - 122. 被引量:1
  • 10马桂芝,滕亮,李文英,贺鑫韬.乳化-溶剂挥发法制备左旋多巴微囊[J].新疆医科大学学报,2014,37(1):47-50. 被引量:9

二级参考文献61

共引文献47

同被引文献28

  • 1中国药典[S].二部.2010. 被引量:61
  • 2Paul HG, Jason MM, Robert CH, et al. Parkinson's disease among American Indians and Alaska natives: a nationwide prevalence study[J]. Mov Disord,2012,27(ll):1456-1459. 被引量:1
  • 3Navailles S, Lagiere M, Contini A, et aL Multisite intraeere- bral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain[J]. ACS Chem Neurosei,2013,4(5) :680-692. 被引量:1
  • 4Lipski J, Nistico R, Berretta N, et al. L-DOPA : a scapegoat foraccelerated neurodegeneration in Parkinson's disease[J]. Prog Neurobiol, 2011,94 (4) ~ 389-407. 被引量:1
  • 5Di SA,Sozio P,Cerasa LS,et al. L-Dopa prodrugs: an overview of trends for improving Parkinsonts disease treatment[J]. Curr Pharm Des, 2011,17 (32) : 3482-3493. 被引量:1
  • 6Paul HG,Jason MM,Robert CH,et al. Parkinson's disease a-mong American Indians and Alaska natives : a nationwideprevalence study[j]. Mov Disord,2012 ,27(11) : 1456-1459. 被引量:1
  • 7Navailles S,Lagiere M, Contini A,et al. Multisite intracere-bral microdialysis to study the mechanism of L-DOPA induceddopamine and serotonin release in the parkinsonian brain [J].ACS Chem Neurosci, 2013 ,4(5) : 680-692. 被引量:1
  • 8Lipski J,Nistico R,Berretta N,et al. L-DOPA: a scapegoat foraccelerated neurodegeneration in Parkinson's disease[J]. ProgNeurobiol,2011,94(4) :389-407. 被引量:1
  • 9Di SA,Sozio P,Cerasa LS,et al.L-Dopa prodrugs: an overviewof trends for improving Parkinson's disease treatment[J].CurrPharm Des,2011,17(32) : 3482-3493. 被引量:1
  • 10Bhandari KH,Newa M,Kim JA, et al. Preparation, charac-terization and evaluation of coenzyme Q10 binary solid disper-sions for enhanced solubility and dissolution [J]. Biol PharmBull, 2007, 30(6):1171-1176. 被引量:1

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部